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Abstract
Objective CXL penetration depth is an important variable influencing clinical treat-
ment effect and safety. The purposes of6 this study were to determine the penetration
depth of CXL in rabbit and equine corneas in epithelium-on and epithelium-off
procedures and to assess an ex vivo fluorescent biomarker staining assay for objective
assessment of CXL penetration depth.
Procedures CXL treatment was performed according to a standardized protocol on 21
and 17 rabbit eyes and on 12 and 10 equine eyes with and without debridement,
respectively. Control corneas were treated similarly, but not exposed to CXL. Hemi-
corneas were stained with either phalloidin and DAPI to visualize intracellular F-actin
and nuclei, or with hematoxylin and eosin. Loss of actin staining was measured and
compared between groups.
Results Epithelium-off CXL caused a median actin cytoskeleton loss with a demarca-
tion at 274 lm in rabbits and 173 lm in horses. In non-CXL-treated controls, we
observed a median actin cytoskeleton loss with a demarcation at 134 lm in rabbits
and 149 lm in horses. No effect was detected in the epithelium-on procedure.
Conclusions CXL penetration depth, as determined by a novel ex vivo fluorescent assay,
shows clear differences between species. A distinct effect was observed following
epithelium-off CXL treatment in the anterior stroma of rabbits, but no different effect
was observed in horses in comparison with nontreated controls. Different protocols
need to be established to effectively treat equine patients with infectious corneal
disease.
Key Words: CXL, fluorescent biomarkers, horse, infectious keratitis, penetration
depth, rabbit
INTRODUCTION
Infectious keratitis in the form of corneal ulceration or
abscessation is a serious and frequently diagnosed condi-
tion in all species treated by veterinary ophthalmologists
and can lead to loss of vision or the globe in severe
cases.1–4 Ulcerative keratitis can progress to keratomalacia
if exogenous and/or endogenous collagenolytic proteinases
cause rapid degradation of the stromal collagen matrix.1,2,5
Deep infectious stromal abscesses underneath an intact
epithelium are more often observed in horses than in
other species. These lesions can be particularly difficult to
treat.2,5,6
Ultraviolet-A (UV-A) cross-linking of corneal collagen
with riboflavin as a photosensitizing agent (CXL) is a
technique which is primarily used for the treatment of
humans with corneal thinning disorders, such as kerato-
conus and ectasia after refractive laser surgery.7–9 CXL
has also shown promising results for the treatment of
corneal infections, melting keratitis, and corneal
edema.10–16 Riboflavin (vitamin B2) acts as a photosensi-
tizer when exposed to UV-A light with a wavelength at
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one of its absorption peaks (370 nm) generating free
radicals, which lead to the formation of additional cova-
lent cross-links at the surface of collagen fibrils and
within the proteoglycan-rich ground substance surround-
ing them.17,18 These cross-links increase corneal biome-
chanical and biochemical stability18–22 through a direct
increase of corneal stiffness and a reduction of enzy-
matic collagenolysis via steric hindrance of the collage-
nase-binding sites on the collagen molecule.17,22 Free
radicals also directly damage microorganisms and lead
to apoptosis of cells in the irradiated area, and finally,
riboflavin may intercalate with nucleic acids within
microorganisms, inhibiting replication.23–25
Because of these biomechanical and biochemical effects,
CXL appears to be a reasonable treatment modality for
keratomalacia in veterinary patients. There are a few
descriptions of the clinical use of CXL in veterinary oph-
thalmology showing promising results.26–30
Diffusion of riboflavin into the corneal stroma leading
to stromal saturation is crucial for the effective absorption
of UV-A radiation in the cornea and thereby determines
both the efficacy and safety of CXL.18,31 The standard
CXL protocol includes epithelial debridement prior to
riboflavin treatment (epithelium-off CXL) to optimize the
diffusion of riboflavin into the stroma. However, corneal
debridement causes marked discomfort and increases the
risk of corneal infections in humans.32–34 Veterinary
patients suffering from keratomalacia usually present with
large epithelial defects so that further debridement might
be unnecessary, but is also unlikely to pose an additional
risk.29,30,35
The standard epithelium-off CXL treatment protocol
first described by Wollensak et al.23 causes keratocyte
apoptosis to a depth of approximately 300 lm in
rabbits. The depth of the treatment can actually be seen
as a demarcation line using slit-lamp biomicroscopy and
anterior segment optical coherence tomography.36,37
Studies in rabbit, porcine, and human corneas demon-
strated a consistent CXL penetration depth and showed
that riboflavin shielding protects all deeper structures,
including the corneal endothelium, iris, lens epithelium,
and retina.31 In human patients, a minimum corneal
thickness of 400 lm is recommended for CXL
treatment.38–40 However, little is known about the
penetration depth of epithelium-off CXL in common
veterinary patient species. As the equine cornea
(812–835 lm)41,42 is approximately 1.5–2 times thicker
than the normal rabbit (400 lm)43 and human
(540 lm)44 corneas, information regarding the maximal
depth at which CXL is effective would be critical for
the treatment of equine patients with deep stromal
abscesses. Thus, the first aim of the study was to deter-
mine the epithelium-off CXL penetration depth in
equine and rabbit corneas. The rabbit data were used to
compare the results of this study to previous studies
evaluating CXL.17,25,45–48
The efficacy of CXL without epithelial debridement
(epithelium-on CXL) is highly variable and decreased
compared to epithelium-off CXL.49–52 Also, the equine
corneal epithelium is more than three times thicker
(131–175 lm)41,42 than the normal rabbit (46 lm)53 and
human (53 lm)54 corneal epithelia. Finally, infectious
stromal abscesses in equine corneas typically reside under-
neath an intact epithelium. Thus, second aim was to
evaluate the penetration depth of epithelium-on CXL in
the equine cornea.
Corneal topography,55 biomicroscopic examination,36
in vivo confocal microscopy,56,57 and anterior segment
optical coherence tomography57 are used for the
assessment of the treatment effect and penetration depth
of CXL in human patients. Descriptions of electron and
light microscopic evaluations exist for cross-linked
human58,59 and rabbit23,48 corneas. Immunohistochemistry
has been performed in cross-linked rabbit corneas25 and
immunofluorescence confocal microscopy in cross-linked
porcine49 corneas. However, a reliable and cost-effective
method to determine CXL penetration depth and the
effect of CXL on corneal stromal cell integrity on a
microscopic level has not yet been established. Jester
et al.60 described an assessment of keratocyte death in
rabbit corneas treated with different irritating materials
using fluorescent biomarkers of cell death and viability.
Finally, the third aim of this study was to evaluate the use
of CXL-induced cell death as an indication of CXL
penetration depth in the cornea.
MATERIALS AND METHODS
Treatment groups
Rabbit and equine eyes were obtained from local abattoirs
immediately after slaughter and placed in serum-free
minimal essential media (MEM) (DMEM; PAA Laborato-
ries, Pasching, Austria). Eyes were examined using a focal
light source and only included if the anterior segment was
normal. Eyes remained in MEM for a maximum of 4 h
prior to further processing. Eyes were washed in sterile
phosphate-buffered saline (PBS) (Dulbecco’s PBS; PAA
Laboratories) and processed according to the respective
treatment group. For each species, the eyes were divided
into five different treatment groups. Group 1: 17 rabbit
and 10 equine eyes underwent epithelium-on CXL. Group
2: 21 rabbit and 12 equine eyes underwent standard
epithelium-off CXL. Group 3: 6 rabbit and 5 equine eyes
were only debrided without subsequent CXL. Group 4: 2
rabbit and 1 equine eyes without any treatment served as
negative controls. Group 5: 2 eyes each were treated with
topical application of 8% NaOH as positive controls of
cell death.
Debridement was performed using an 8-mm-diameter
sharp biopsy punch (Biopsy Punch Stiefel; GlaxoSmithK-
line, Muenchenbuchsee, Switzerland) to outline the area
to be debrided and a microsurgical blade (Miniature Blade
© 2015 American College of Veterinary Ophthalmologists, Veterinary Ophthalmology, 1–10
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no 64; Katena Products, Denville, NJ, USA) to manually
remove the epithelium. Care was taken not to damage the
corneal stroma. Treatment with NaOH was performed by
topical application of a Schirmer tear test strip (Intervet/
Schering-Plough; Animal Health, Roseland, NJ, USA)
soaked with 8% NaOH on the central cornea for 20 s.
Equine corneas were debrided prior to application of
NaOH to allow sufficient penetration into the stroma.
Rabbit corneas were not debrided as NaOH caused
complete epithelial destruction as well as keratocyte cell
loss throughout the stroma as determined in preliminary
studies. Eyes were placed in tissue culture plates, cornea
side up, with each well filled with MEM until the medium
level reached the limbus.
CXL procedure
CXL was performed following the standard protocol as
described previously.8,26 Briefly, the cornea of each eye
was pretreated with photosensitizing iso-osmolar 0.1%
riboflavin drops (freshly mixed 0.5% aqueous riboflavin
(Vit B2; Streuli, Uznach, Switzerland) and sterile 20%
dextran T-500 solutions) for 30 min. Every 3 min, one
drop was placed on the central cornea. A plastic ring of
8 mm or 20 mm diameter was placed on the cornea to
prevent excessive fluid drain in rabbit and equine eyes,
respectively. The cornea was then irradiated for 30 min
with 365-nm wavelength UV-A light (irradiance: 3 mW/
cm2, UV-X; Peschke Meditrade, Cham, Switzerland)
focused on the corneal surface. Riboflavin solution was
applied to the cornea every 3 min during the irradiation
period.
Further processing
After the CXL procedure, all eyes were rinsed twice with
PBS, followed by two rinses with MEM. The eyes were
then placed in new 12-well tissue culture plates or in con-
tainers large enough to accommodate the entire equine
eye. The eyes were placed cornea side up and covered
with MEM. Eyes were incubated at room temperature and
atmosphere for 24 h and then placed in a 10% formalin
solution for overnight fixation.
After fixation, the cornea of each eye was removed and
bisected. A 3-mm-wide, central strip of each hemicornea
was used for the preparation of frozen and paraffin-
embedded sections, respectively. Tissue for fluorescence
microscopy was flash-frozen in liquid nitrogen and then
stored at 20 °C overnight. Corneal strips were embed-
ded in optimal cutting temperature compound (OCT;
Biosystems, Nunningen, Switzerland) prior to section
preparation. Four 7-lm-thick tissue sections of each cor-
neal strip were collected and placed onto positively
charged glass slides (SuperFrost; Biosystems) (2 sections/
slide).
Slides were washed four times for 3 min with PBS and
then blocked with 1% bovine serum albumin (BSA;
Sigma-Aldrich, Buchs, Switzerland) in PBS for 1 h. Slides
were stained with rhodamine-labeled phalloidin (R415
rhodamine phalloidin; Life Technologies, Zug, Switzer-
land), using three units per section, diluted 1:2 in PBS to
label cells unaffected by the CXL procedure, and counter-
stained with 40,6-diamidino-2-phenylindole (DAPI) at a
1:1000 dilution in PBS (DAPI 300 nM; Life Technologies)
to label cell nuclei. Staining was performed for 2 h. All
sections were washed four times for 3 min with PBS and
then cover-slipped using mounting medium (Fluoromount
FP-483331; Interchim, Montlucon, France).
The paraffin-embedded second hemicornea was routinely
sectioned and stained with hematoxylin and eosin (HE).
Evaluation
Fluorescent sections were evaluated at 109 magnification
with an epifluorescence microscope equipped with appro-
priate filters (Leica DM 6000B; Leica Microsystems,
Heerbrugg, Switzerland). To acquire an adequate image
of each whole corneal section, a number of single images
were acquired and merged into one composite image
using a microscope compatible camera (Leica DFC 350
FX; Leica Microsystems, Mannheim, Germany) and speci-
fic merging software (Leica Microsystems). Fluorescent
images were viewed and analyzed using IMAGEJ software
(developed by Wayne Rasband, National Institutes of
Health, Bethesda, MD, USA; available at http://
rsb.info.nih.gov/ij/index.html).
Light microscopic images were scanned (NanoZoomer
2.0; Hamamatsu, Solothurn, Switzerland), viewed, and
analyzed using special software (NDP.view2; Hama-
matsu).
Two different observers (NG and SP) independently
evaluated 2–4 sections of each cornea quantitatively and
qualitatively. Qualitative evaluations were performed on
all three different stains. On phalloidin-stained slides,
actin cytoskeleton staining and collagen compaction were
evaluated. The absence of actin cytoskeleton staining indi-
cates cellular disintegration and, therefore, keratocyte
death,60 which was interpreted as immediate visible effect
indicating penetration depth of the CXL treatment.
DAPI-stained slides were used for the evaluation of
keratocyte nucleus morphology. HE-stained slides were
used for evaluation of keratocyte nucleus morphology and
collagen compaction. Pyknotic nuclei are signs of cell
death and were also considered as visible effect
indicating penetration depth of the CXL treatment. Quan-
titative evaluations were only performed on phalloidin-
stained specimens. Measurements of actin cytoskeleton
staining loss, which was interpreted as the penetration
depth of the CXL procedure, were performed at three
different locations in each corneal section as previously
described by Jester et al.60 and as shown in Fig. 1: The
entire stromal thickness and the depth of actin cytoskele-
ton staining loss were measured. The latter distance
was reported in lm and as a percentage of total stromal
thickness.
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Statistical analysis
Statistical analysis was performed using the programs
lme4 and nlme of R statistical software (www.r-
project.org). A linear mixed effects model was used to
assess differences between groups and between observers.
To avoid potential clustering within eyes, these were trea-
ted as random effect. Model selection was based on Akaike
information criterion (AIC) with lower values indicating a
better model fit. Statistical significance was defined as
P < 0.05.
RESULTS
The qualitative results are supported by the quantitative
evaluation. The results of the quantitative evaluation are
shown in Fig. 2.
No statistically significant differences in measurements
were registered between the two observers.
Epithelium-off CXL penetration depth in rabbit and equine
corneas
Rabbit eyes that underwent standard epithelium-off CXL
(group 2) demonstrated visible effects in the anterior one-
third to half of the corneal stroma. On phalloidin-stained
slides, actin cytoskeleton staining was absent in the
anterior one-third to half of the corneal stroma. This area
of actin cytoskeleton staining loss overlapped with an area
of anterior stromal collagen compaction (Fig. 3d). On
DAPI-stained slides, keratocyte nuclei appeared smaller
and more fluorescent in the anterior one-third to half of
the stroma (Figs 3e and f). Arrows in Fig. 3f indicate
pyknotic nuclei and arrowheads indicate nucleus
fragments. The zone of pyknotic nuclei overlapped with
the zone of actin cytoskeleton staining loss and collagen
compaction. On HE-stained slides, keratocyte nuclei
appeared pyknotic in the anterior one-third and there was
collagen compaction in the anterior half to two-thirds of
the stroma (Figs 3g and h). A sharp delineation between
untreated peripheral and treated central stroma was visible
(Fig. 3g). These effects were significantly different from
the effects observed in the positive and negative control
groups (groups 3, 4 and 5).
Rabbit corneas that underwent standard epithelium-off
CXL (group 2) showed a median penetration depth of
274 lm (interquartile range IQR: 235–330 lm). This corre-
sponded to 32% (IQR: 28–38%) of the total stromal thick-
ness. Rabbit corneas that were only debrided without
subsequent CXL (group 3) showed a median actin cytoskele-
ton staining loss of 134 lm (IQR: 112–168 lm) or 13%
(IQR: 11–15%) of the total stromal thickness. The actin loss
in rabbit corneas that underwent epithelium-off CXL was
statistically significantly larger than the actin loss of rabbit
corneas undergoing debridement alone (P < 0.001) (Fig. 2).
Equine corneas that underwent epithelium-off CXL
(group 2) also demonstrated actin cytoskeleton staining
loss and collagen compaction in the phalloidin-stained
slides. However, this effect was restricted to the most
superficial anterior stroma, comprising one tenth or less of
the total stromal thickness (Figs 4d and e). On DAPI-
stained slides, pyknotic nuclei overlapped with the zone of
superficial actin cytoskeleton staining loss (data not
shown). On HE-stained slides, pyknotic nuclei were
visible in the most superficial anterior stroma, but no
collagen compaction could be appreciated (Fig. 4f). Apart
from the collagen compaction observed in the phalloidin-
stained slides, these effects were identical to the effects
observed in the negative control group (both rabbit and
equine corneas) receiving debridement alone without
subsequent CXL (group 3).
Figure 1. Phalloidin-stained rabbit cornea that underwent
epithelium-off CXL. The yellow lines indicate the manner in which
measurements were performed. The entire stromal thickness and the
depth of visible actin cytoskeleton staining loss, which coincides with
the area in which the collagen lamellae are compacted, were
measured at three different locations in each corneal section as
previously described by Jester et al.60
Figure 2. Boxplot image comparing the median penetration depth in
lm in rabbit corneas (left) and equine corneas (right). Corneas were
subjected to debridement and CXL (experimental group 2:
epithelium-off CXL) and debridement only (experimental group 3).
In rabbits, the absolute actin cytoskeleton staining loss was
significantly deeper in corneas that underwent debridement and CXL
than in corneas that were debrided only (**P < 0.001). In horses, no
statistically significant difference was observed between the two
groups. The median penetration depth in absolute numbers was
statistically significantly deeper in rabbit than in equine corneas that
underwent debridement and CXL (*P < 0.01).
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Equine corneas that underwent epithelium-off CXL
(group 2) showed a median penetration depth of 173 lm
(IQR: 137–246 lm) or 9% (IQR: 6–14%) of the total stro-
mal thickness. The penetration depth of the epithelium-off
CXL procedure in lm was statistically significantly less in
equine corneas compared to rabbit corneas (P < 0.01)
(Fig. 2).
Equine corneas that were only debrided without
subsequent CXL (group 3) showed a median actin
cytoskeleton staining loss of 149 lm (IQR: 126–177 lm)
or 8% (IQR: 7–10%) of the total stromal thickness. This
did not statistically significantly differ from the median
actin cytoskeleton staining loss of equine corneas undergo-
ing epithelium-off CXL (P = 0.401) (Fig. 2).
Epithelium-on CXL penetration depth in equine corneas
Rabbit and equine eyes that underwent epithelium-on
CXL (group 1) were similar to untreated negative controls
(group 4) for all stains (Figs 3a–c and 4a–c): Collagen
lamellae were evenly spaced with mildly higher packing
density in the anterior stroma when compared to the
posterior stroma. Cell nuclei were of regular dimensions
and were evenly spaced throughout the stroma.
Rabbit and equine corneas that underwent epithelium-
on CXL (group 1) and untreated rabbit and equine
corneas (group 4) did not show any measurable effect:
penetration depth 0% (data not shown).
Rabbit and equine eyes treated with topical application
of NaOH (group 5) showed complete cell loss in all layers
of the cornea underneath the treated area in DAPI-,
phalloidin-, and HE-stained specimens and thus a penetra-
tion depth of 100% (data not shown).
Evaluation of the use of CXL-induced cell death as an
indication of CXL penetration depth in the cornea
The results observed via fluorescent (phalloidin and
DAPI) and conventional light microscopy demonstrated
good correlation within this study and with published data.
(a) (b) (c)
(d) (e) (f)
(g) (h) (i)
Figure 3. The penetration depth of CXL in rabbit corneas in the presence or absence of the corneal epithelium. (a–c) Epithelium-on CXL,
note normal appearance of cornea. (d–i) Epithelium-off CXL. (d) Actin cytoskeleton staining loss and collagen compaction, outlined by the
white arrow, were visible in the anterior third of the stroma. Swelling of the posterior stroma and an increased total corneal thickness can be
observed. (e) Cell nuclei in the anterior third of the stroma were smaller and more fluorescent. (f) Magnification of (e). Pyknotic nuclei and
nucleus fragments is indicated by the white arrows and arrowheads, respectively. (g) Collagen compaction is present in the anterior two-thirds of
the stroma and is indicated by the black arrow. The arrowheads outline the sharp delineation between untreated peripheral and treated central
cornea. (h) Magnification of anterior stroma of (g). Arrows indicate pyknotic nuclei in the anterior third of the stroma. (i) Magnification of
posterior stroma of (g). Keratocyte nuclei are larger and more regularly shaped than in the anterior stroma. 7
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DISCUSSION
The present study demonstrated that fluorescent
biomarkers could be used to reliably determine CXL-
induced stromal cell loss, which was interpreted as a
measure of immediate CXL treatment effect and pene-
tration depth. Stromal collagen compaction and changes
in keratocyte nucleus morphology as a result of epithe-
lium-off CXL in the anterior 300 lm of stroma have
been described previously and were observed to overlap
with the zone of actin loss in epithelium-off CXL-trea-
ted corneas in the present study.23,25,49 The epithelium-
off CXL penetration depth observed in rabbits in the
present study (median 274 lm) corresponded well with
the published literature.23,61 The effect of epithelium-off
CXL in equine corneas was evaluated for the first time
and epithelium-off CXL demonstrated an unexpectedly
shallow effect in the equine cornea (median 173 lm).
Interestingly, the demarcated epithelium-off CXL pene-
tration depth in absolute numbers was significantly larger
in rabbit compared to equine corneas. Loss of actin
cytoskeleton staining, as an indicator of keratocyte
death,60 is a known effect observed after debridement
alone23,62–64 and was observed in the present study.
Specifically, rabbit and equine corneas that were just
debrided demonstrated actin cytoskeleton staining loss
and pyknotic nuclei, but these effects were only
visualized in the most anterior stroma, and collagen
compaction was not observed. Actin loss was observed to
a significantly greater depth in the stroma of rabbit cor-
neas treated with epithelium-off CXL compared to cor-
neas that were only debrided.47 The penetration depth
in equine corneas that underwent epithelium-off CXL
was superficial and could not be distinguished from the
effect of debridement alone.
The effect of epithelial debridement prior to the
CXL procedure on CXL penetration depth was pro-
found in the present study. No effect could be observed
in rabbit and horse eyes undergoing epithelium-on
CXL. This result also corresponds to a recently pub-
lished study in humans showing no effect of epithelium-
on CXL in progressive keratoconus with a follow-up of
2 years.50 The tight junctions of the corneal epithelium
act as a major permeability barrier to riboflavin/dextran
solutions, and debridement is therefore regarded as a
prerequisite for the standard CXL protocol.8,40,49–52,65
On the other hand, epithelial debridement carries the
disadvantages of discomfort and greater risk for infec-
tions in humans.32,34 For these reasons, several studies
have evaluated alternatives to achieve sufficient stromal
riboflavin concentrations without debridement, using a
variety of methods.32,34,65–69
Rosetta et al.35 and Famose et al.29,30 described the
application of CXL with a window application for infec-
tious ulcerative keratitis, whereby riboflavin penetration
into the stroma is obtained through the epithelial defect
(a) (b) (c)
(d) (e) (f)
Figure 4. The penetration depth of CXL in equine corneas in the presence or absence of the corneal epithelium. (a–c) Epithelium-on CXL,
note normal appearance of cornea. (d–f) Epithelium-off CXL. (d) Actin cytoskeleton staining loss and collagen compaction at the anterior
margin of the stroma. (e) Magnification of (d). The white arrow outlines the actin cytoskeleton loss and collagen compaction. (f) Pyknotic nuclei
are visible in the anterior margin of the stroma and are outlined by black arrows.
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overlying the ulcer without or with minimal further
debridement. This window application demonstrates
that corneas with an intact epithelium may only need
debridement of a small area of epithelium to allow for
sufficient riboflavin diffusion.
The penetration depth has not been studied in horses
before and the question now arises how effective CXL
(epithelium-on and epithelium-off) in this species would
be clinically, especially for deep stromal pathologies and
in view of a greater stromal thickness in horses when
compared to other species. A recent clinical case series
described CXL treatment in addition to medical therapy
in nine horses with ulcerative keratitis.28 The authors
applied the standard CXL protocol and judged postop-
erative scarring as impressively mild and the healing
time as rather fast in eight of nine horses. One horse
with fungal keratitis was enucleated at 4 days after treat-
ment due to panophthalmitis. Because of the low num-
ber of patients and the absence of a control group in
the study, the authors concluded that CXL might
potentially be useful for the treatment of stromal ulcers
in horses.28,70 However, the results of the present study
suggest that efficacy would not be expected with epithe-
lium-on or off CXL in horses with infectious keratitis
because CXL was unable to penetrate beyond the super-
ficial normal equine cornea. Further studies are required
to determine CXL penetration depth in infected equine
corneas with or without keratomalacia. The current
CXL protocols need modification to modulate CXL
penetration depth and thus fit various species and treat-
ment indications. A tailored increase in total radiation
energy delivery might increase CXL penetration depth
in the thick equine cornea and also increase the antimi-
crobial effect without elevating the risk for endothelial
damage.
The detection method for CXL penetration (assessment
of cell death and collagen compaction) was a possible limi-
tation of the present study. An inconsistent correlation
between the degree of keratocyte apoptosis and corneal
mechanical stiffening has been observed in a mouse model
for CXL (Kling S. et al., personal communication8 ). This
suggests that the apoptotic effects of CXL do not neces-
sarily correlate with the depth or degree to which the
physicochemical CXL effects occur in the cornea. These
effects would not have been observed in the corneas used
in this study, because only cytotoxic effects were evalu-
ated.
Significant differences in riboflavin-mediated UV-A
absorption rates were not observed between human, por-
cine, bovine, and equine corneas in a recent study
(Wuarin R. et al., personal communication9 ). The authors
concluded that the known riboflavin diffusion rates for
humans can be used without modification and that a
species-specific customization of CXL in terms of
riboflavin saturation should not be necessary. However,
riboflavin-mediated UV-A absorption is only one of
several elements influencing the effectiveness of CXL:
Interspecies variations in ECM and proteoglycan
composition71 may affect covalent bond formation in the
corneal stroma.72 Energy delivery may thus need to be
adapted to specific species, independently of species-
specific corneal thickness. Other possible reasons for the
shallower zone of CXL penetration and keratocyte loss
in horses could be differences in oxygen availability or
keratocyte susceptibility to free radical-induced
damage.73
Assessment of the relative penetration depth of CXL
presented a challenge in the present study, as corneas
incubated in medium for 24 h inevitably show stromal
swelling that primarily occurs in the posterior stroma.74
A reduced swelling capacity of the anterior cross-linked
stroma has been described75; therefore, assessment of
the absolute penetration depth seems reasonable, but the
relation of the anterior cross-linked stroma to the total
stromal thickness might be erroneous. In the present
study, different posterior stromal swelling capacities were
determined in cryopreserved sections compared to
paraffin-embedded sections. This observation is probably
caused by dehydration, clearing, and paraffin wax
embedding of the HE sections, which did not affect the
cryopreserved sections, used for the fluorescence
images.76,77
The authors think that 10the anterior cross-linked to total
stromal thickness ratio of 2/3 observed in the paraffin-
embedded sections (Fig. 3g) might be more representative
of the true effect than the anterior cross-linked to total
stromal thickness ratio of 1/3 observed in the cryopreserved
sections. This assumption is based on the following calcula-
tion: If the cross-linked anterior two-thirds of the stroma
in rabbits correlates with 274 lm (the median CXL
penetration depth observed in this species), the total
stromal thickness of the same cornea is approximately
274 + 137 = 411 lm, which corresponds to the published
corneal thickness in rabbits.43
In conclusion, the present study shows that the absolute
penetration depth of CXL can be determined using
fluorescent biomarkers. The current CXL protocols need
modification to fit various species and treatment indica-
tions, as demonstrated in the equine corneas in this study.
In addition to transepithelial riboflavin permeability,
future studies should focus on the modulation of CXL
penetration depth in horses.
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